References
Neifert SN, Chapman EK, Martini ML, et al. Aneurysmal subarachnoid hemorrhage: the last decade. Transl Stroke Res. 2021;12(3):428–46. https://doi.org/10.1007/s12975-020-00867-0.
Dodd WS, Laurent D, Dumont AS, et al. Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J Am Heart Assoc. 2021;10(15):e021845. https://doi.org/10.1161/JAHA.121.021845.
Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618–25. https://doi.org/10.1016/S1474-4422(11)70108-9.
Macdonald RL, Higashida RT, Keller E, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463–9. https://doi.org/10.1161/STROKEAHA.111.648980 ([published correction appears in Stroke. 2012 Jul;43(7):e68]).
Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet. 2012;380(9836):44–9. https://doi.org/10.1016/S0140-6736(12)60724-7.
Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD, STASH Collaborators. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 2014;13(7):666–75. https://doi.org/10.1016/S1474-4422(14)70084-5.
Carlson AP, Hänggi D, Wong GK, et al. Single-dose intraventricular nimodipine microparticles versus oral nimodipine for aneurysmal subarachnoid hemorrhage. Stroke. 2020;51(4):1142–9. https://doi.org/10.1161/STROKEAHA.119.027396.
Grossen AA, Ernst GL, Bauer AM. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis. Neurosurg Focus. 2022;52(3):E10. https://doi.org/10.3171/2021.12.FOCUS21629.
Warach SJ, Dula AN, Milling TJ Jr. Tenecteplase thrombolysis for acute ischemic stroke. Stroke. 2020;51(11):3440–51. https://doi.org/10.1161/STROKEAHA.120.029749.
Keric N, Döbel M, Krenzlin H, et al. Comparative analysis of fibrinolytic properties of alteplase, tenecteplase and urokinase in an in vitro clot model of intracerebral haemorrhage. J Stroke Cerebrovasc Dis. 2020;29(9):105073. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105073 [published correction appears in J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105338].
Author information
Authors and Affiliations
Contributions
WY contributed to the conception, literature review, manuscript draft, and final revision.
Corresponding author
Ethics declarations
Ethics Approval
This review article does not involve direct human research and therefore requires no ethical approval.
Conflict of Interest
The author declares no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yu, W. Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Recent Advances and Future Directions in Translational Research. Transl. Stroke Res. 14, 119–120 (2023). https://doi.org/10.1007/s12975-022-01028-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-022-01028-1